Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD

References

• GuarascioAJRaySMFinchCKSelfTHThe clinical and economic burden of chronic obstructive pulmonary disease in the USAClinicoecon Outcomes Res2013523524523818799
   PubMedGoogle Scholar
• BourbeauJFordGZackonHPinskyNLeeJRubertoGImpact on patients’ health status following early identification of a COPD exacerbationEur Respir J200730590791317715163
   PubMed Web of Science ®Google Scholar
• DonaldsonGSeemungalTBhowmikAWedzichaJRelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
   PubMed Web of Science ®Google Scholar
• JinjuvadiaCJinjuvadiaRMandapakalaCDurairajanNLiangpunsakulSSoubaniAOTrends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010COPD2017141727927419254
   PubMedGoogle Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMMorgenthalerNGCopeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPDChest200713141058106717426210
   PubMed Web of Science ®Google Scholar
• SchleichFCorhayJLLouisRBlood eosinophil count to predict bronchial eosinophilic inflammation in COPDEur Respir J201645515621564
   Web of Science ®Google Scholar
• BarnesNCSharmaRLettisSCalverleyPMBlood eosinophils as a marker of response to inhaled corticosteroids in COPDEur Respir J201637513741382
   Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121861485522447964
   PubMed Web of Science ®Google Scholar
• Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in COPD: the Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPDThorax201671211812526585525
   PubMed Web of Science ®Google Scholar
• WatzHTetzlaffKWoutersEFBlood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialLancet Respir Med20164539039827066739
   PubMed Web of Science ®Google Scholar
• SalturkCKarakurtZAdiguzelNDoes eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?Int J Chron Obstruct Pulmon Dis2015101837184626392758
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJCosioBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
   PubMed Web of Science ®Google Scholar
• SinDDMiravitllesMManninoDMWhat is asthma−COPD overlap syndrome? Towards a consensus definition from a round-table discussionEur Respir J201648366467327338195
   PubMed Web of Science ®Google Scholar
• GolpeRSanjuan LopezPCano JimenezECastro AnonOPerez de LlanoLADistribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smokeArch Bronconeumol201450831832424576449
   PubMed Web of Science ®Google Scholar
• CosioBGSorianoJBLópez-CamposJLCHAIN StudyDefining the Asthma-COPD Overlap Syndrome in a COPD CohortChest20161491455226291753
   PubMed Web of Science ®Google Scholar
• MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
   PubMed Web of Science ®Google Scholar
• PostmaDSRabeKFThe Asthma-COPD overlap syndromeN Engl J Med2015373131241124926398072
   PubMed Web of Science ®Google Scholar
• BafadhelMGreeningNJHarvey-DunstanTCBlood eosinophils and outcomes in severe hospitalised exacerbations of COPDChest2016150232032826851799
   PubMed Web of Science ®Google Scholar
• LeeJYChonGRRheeCKCharacteristics of patients with chronic obstructive pulmonary disease at the first visit to a pulmonary medical center in Korea: The KOrea COpd Subgroup Study Team CohortJ Korean Med Sci201631455356027051239
   PubMed Web of Science ®Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]2017 Available from: http://goldcopd.orgAccessed April 5, 2017
   Google Scholar
• ZeigerRSSchatzMLiQHigh blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthmaJ Allergy Clin Immunol Pract20142674175025439366
   PubMed Web of Science ®Google Scholar
• DiSantostefanoRLHindsDVan LeHBarnesNCRelationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohortRespir Med2016112889626872700
   PubMed Web of Science ®Google Scholar
• GeorgeLBrightlingCEEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseTher Adv Chronic Dis201671345126770668
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CatalunaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450suppl 1116
   PubMed Web of Science ®Google Scholar
• LavinskieneSMalakauskasKJerochJHoppenotDSakalauskasRFunctional activity of peripheral blood eosinophils in allergen-induced late-phase airway inflammation in asthma patientsJ Inflamm (Lond)2015122525829869
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSAnzuetoABarnesNBlood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysisLancet Respir Med20164973174127460163
   PubMed Web of Science ®Google Scholar
• NurwidyaFDamayantiTYunusFThe role of innate and adaptive immune cells in the immunopathogenesis of chronic obstructive pulmonary diseaseTuberc Respir Dis (Seoul)201679151326770229
   PubMedGoogle Scholar
• WurstKEKelly-ReifKBushnellGAPascoeSBarnesNUnderstanding asthma-chronic obstructive pulmonary disease overlap syndromeRespir Med201611011126525374
   PubMed Web of Science ®Google Scholar
• van der HeideSde MonchyJGRde VriesKBrugginkTMKauffmanHFSeasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthmaJ Allergy ClinImmunol1994932470475
   PubMed Web of Science ®Google Scholar